1. Efficacy of alprostadil for preventing of contrast-induced nephropathy: A meta-analysis
   Jing-Zhan Zhang et al, 2017, Scientific Reports CrossRef
2. Prostaglandin E1 administration for prevention of contrast-induced acute kidney injury
   Ning Geng et al, 2018, Medicine CrossRef
3. The Preventive Effect of Alprostadil on the Contrast-Induced Nephropathy of Coronary Heart Disease Treated by Percutaneous Coronary Intervention in Moderate and High-Risk Population Stratified by Mehran Score
   Xiaogang Liu et al, 2022, Angiology CrossRef
4. Efficacy of Alprostadil in Preventing Contrast-Induced Nephropathy: A Systematic Review and Meta-Analysis
   Hongling Xu et al, 2021, Angiology CrossRef
5. Alprostadil protects type 2 diabetes mellitus patients treated with metformin from contrast-induced nephropathy
   Jing Wang et al, 2017, International Urology and Nephrology CrossRef
6. Effectiveness of contrast-associated acute kidney injury prevention methods; a systematic review and network meta-analysis
   Khalid Ahmed et al, 2018, BMC Nephrology CrossRef
7. Preventive Effects of Alprostadil Against Contrast-Induced Nephropathy Inpatients With Renal Insufficiency Undergoing Percutaneous Coronary Intervention
   Shi-Cheng Yang et al, 2018, Angiology CrossRef
8. Efficacy of alprostadil in preventing contrast‐induced nephropathy in patients undergoing percutaneous coronary intervention: A multicenter prospective randomized controlled trial
   Min Liang et al, 2018, Catheterization and Cardiovascular Interventions CrossRef